![Jeffrey Meckler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Meckler
Directeur/Membre du Conseil chez
TRAVERE THERAPEUTICS, INC.
Fortune : 5 M $ au 31/05/2026
Profil
Jeffrey A. Meckler currently works at Children of Bellevue, Inc., as Director from 2001 and Travere Therapeutics, Inc., as Independent Director from 2016.
Mr. Meckler also formerly worked at Cypress Bioscience, Inc., as Chief Executive Officer & Director from 2011 to 2012, Cocrystal Pharma, Inc., as Chief Executive Officer & Director from 2015 to 2016, Trieber Therapeutics, Inc., as Chief Executive Officer in 2017, Indaptus Therapeutics, Inc., as Chief Executive Officer & Director from 2021 to 2025, Intec Parent, Inc. (United States), as President, CEO, Secretary & Director, Intec Pharma Ltd., as Vice Chairman & Chief Executive Officer from 2017 to 2021, QLT, Inc., as Independent Director from 2014 to 2016, Alveolus, Inc., as Director from 2007 to 2009, Andra Group, Inc., as Managing Director, Kyalin Biosciences, Inc., as Director from 2011 to 2012, and Clearfarma USA, as Director from 2010 to 2012.
Mr. Meckler received his graduate degree from Fordham University School of Law and undergraduate degree and graduate degree from Tepper School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/05/2026 | 91 500 ( 0,1 % ) | 4 M $ | 31/05/2026 | |
| 11/02/2026 | 229 929 ( 0,17 % ) | 404 675 $ | 31/05/2026 |
Postes actifs de Jeffrey Meckler
| Sociétés | Poste | Début |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 18/05/2016 |
Children of Bellevue, Inc.
 Children of Bellevue, Inc. Miscellaneous Commercial ServicesCommercial Services Develops funds and programs to improve the health and well-being of children | Directeur/Membre du Conseil | 01/01/2001 |
Anciens postes connus de Jeffrey Meckler
| Sociétés | Poste | Fin |
|---|---|---|
Intec Pharma Ltd.
 Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Directeur Général | 01/08/2021 |
Trieber Therapeutics, Inc.
 Trieber Therapeutics, Inc. BiotechnologyHealth Technology Engages in bio-technology research and development | Directeur Général | 01/07/2017 |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Directeur Général | 24/10/2014 |
| COCRYSTAL PHARMA, INC. | Directeur Général | 22/07/2016 |
Clearfarma USA | Directeur/Membre du Conseil | 01/11/2012 |
Formation de Jeffrey Meckler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Develops drugs, diagnostics and other therapeutic products | Health Technology |
Alveolus, Inc.
 Alveolus, Inc. Medical SpecialtiesHealth Technology Develops non-vascular interventional stent technology | Health Technology |
Children of Bellevue, Inc.
Children of Bellevue, Inc. Miscellaneous Commercial ServicesCommercial Services Develops funds and programs to improve the health and well-being of children | Commercial Services |
Andra Group, Inc.
 Andra Group, Inc. Apparel/Footwear RetailRetail Trade Sells men's clothes through online | Retail Trade |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Health Technology |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Fordham University School of Law
 Fordham University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tepper School of Business
 Tepper School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyalin Biosciences, Inc.
 Kyalin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Cocrystal Pharma, Inc.
 Cocrystal Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for use in the treatment of human viral diseases | Health Technology |
Clearfarma USA | |
Trieber Therapeutics, Inc.
Trieber Therapeutics, Inc. BiotechnologyHealth Technology Engages in bio-technology research and development | Health Technology |
Intec Parent, Inc. (United States) | |
Indaptus Therapeutics, Inc.
 Indaptus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Choisissez Zonebourse 
